Journal
Clinical Cancer Research
Publication Date
9-3-2024
Volume
30
Issue
17
First Page
3855
Last Page
3867
Document Type
Open Access Publication
DOI
10.1158/1078-0432.CCR-23-3980
Rights and Permissions
Suvilesh KN, Manjunath Y, Nussbaum YI, Gadelkarim M, Raju M, Srivastava A, Li G, Warren WC, Shyu CR, Gao F, Ciorba MA, Mitchem JB, Rachagani S, Kaifi JT. Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non-Small Cell Lung Cancer Patient-Derived Tumor Organoids. Clin Cancer Res. 2024 Sep 3;30(17):3855-3867. doi: 10.1158/1078-0432.CCR-23-3980 This open access article is distributed under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. ©2024 The Authors; Published by the American Association for Cancer Research
Recommended Citation
Suvilesh, Kanve N; Manjunath, Yariswamy; Nussbaum, Yulia I; Gadelkarim, Mohamed; Raju, Murugesan; Srivastava, Akhil; Li, Guangfu; Warren, Wesley C; Shyu, Chi-Ren; Gao, Feng; Ciorba, Matthew A; Mitchem, Jonathan B; Rachagani, Satyanarayana; and Kaifi, Jussuf T, "Targeting AKR1B10 by drug repurposing with epalrestat overcomes chemoresistance in non-small cell lung cancer patient-derived tumor organoids." Clinical Cancer Research. 30, 17. 3855 - 3867. (2024).
https://digitalcommons.wustl.edu/oa_4/4178
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
